Nationwide Children’s Hospital/Ohio State University
Residency, Pediatrics, 1978-1979
Nationwide Children’s Hospital/Ohio State University
Fellowship, Pediatric Surgery, 1977-1978
University of Colorado
Residency, Surgery, 1972-1977
Tufts University School of Medicine
Medical School
CO State Medical License
Active through 2025
MA State Medical License
Active through 2025
OH State Medical License
Active through 2024
ACS Fellow
Embracing early recovery after surgery (ERAS) protocols: Is it time for otolaryngology to join the parade?
Gerald M. Haase
Oxidative Damage and Inflammation Biomarkers: Strategy in Hearing Disorders.
Gerald M. Haase, Kedar N. Prasad
The Management of Synchronous Bilateral Wilms Tumor: A Report from the National Wilms Tumor Study Group
Thomas E. Hamilton, Michael L. Ritchey, Gerald M. Haase, Pedram Argani, Susan M. Peterson, James R. Anderson, Daniel M. Green, Robert C. Shamberger
Antioxidant micronutrient impact on hearing disorders: concept, rationale, and evidence
Gerald M. Haase, Kedar N. Prasad, William C. Cole, Jewell M. Baggett-Strehlau, Suzanne E. Wyatt
Outcomes of children with favorable histology wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5.
John A. Kalapurakal, Daniel M. Green, Gerald M. Haase, James R. Anderson, Jeffrey S. Dome, Paul E. Grundy
Long-term outcomes for infants with very low risk wilms tumor treated with surgery alone in national wilms tumor study-5
Robert C. Shamberger, James R. Anderson, Norman E. Breslow, Elizabeth J. Perlman, J. Bruce Beckwith, Michael L. Ritchey, Gerald M. Haase, Milton Donaldson, Paul E. Grundy, Robert M. Weetman, Max J. Coppes, Marcio H. Malogolowkin, Patricia Shearer, Morris Kletzel, Patrick R.M. Thomas, Roger M. Macklis, Vicki Huff, Douglas A. Weeks, Daniel M. Green
Intraoperative spillage of favorable histology wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. A report from the National Wilms Tumor Study Group.
John A. Kalapurakal, Sierra M. Li, Norman E. Breslow, J. Bruce Beckwith, Michael L. Ritchey, Robert C. Shamberger, Gerald M. Haase, Patrick R.M. Thomas, Paul E. Grundy, Daniel M. Green, Giulio J. D’Angio
Ureteral extension in Wilms’ tumor: a report from the National Wilms’ Tumor Study Group (NWTSG)
Michael L. Ritchey, Shane M. Daley, Robert C. Shamberger, Peter F. Ehrlich, Thomas E. Hamilton, Gerald M. Haase, Robert S. Sawin
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Marcio H. Malogolowkin, Cecilia A. Cotton, Daniel M. Green, Norman E. Breslow, Elizabeth J. Perlman, James S. Miser, Michael L. Ritchey, Patrick R.M. Thomas, Paul E. Grundy, Giulio J. D’Angio, J. Bruce Beckwith, Robert C. Shamberger, Gerald M. Haase, Milton Donaldson, Robert M. Weetman, Max J. Coppes, Patricia Shearer, Peter F. Coccia, Morris Kletzel, Roger M. Macklis, Gail E. Tomlinson, Vicki Huff, Robert O. Newbury, Douglas Weeks
Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.
Daniel M. Green, Cecilia A. Cotton, Marcio H. Malogolowkin, Norman E. Breslow, Elizabeth J. Perlman, James S. Miser, Michael L. Ritchey, Patrick R.M. Thomas, Paul E. Grundy, Giulio J. D’Angio, J. Bruce Beckwith, Robert C. Shamberger, Gerald M. Haase, Milton Donaldson, Robert M. Weetman, Max J. Coppes, Patricia Shearer, Peter F. Coccia, Morris Kletzel, Roger M. Macklis, Gail E. Tomlinson, Vicki Huff, Robert O. Newbury, Douglas A. Weeks
Treatment of Anaplastic Histology Wilms’ Tumor: Results From the Fifth National Wilms’ Tumor Study
Jeffrey S. Dome, Cecilia A. Cotton, Elizabeth J. Perlman, Norman E. Breslow, John A. Kalapurakal, Michael L. Ritchey, Paul E. Grundy, Marcio H. Malogolowkin, J. Bruce Beckwith, Robert C. Shamberger, Gerald M. Haase, Max J. Coppes, Peter F. Coccia, Morris Kletzel, Robert M. Weetman, Milton Donaldson, Roger M. Macklis, Daniel M. Green
Radiation therapy for favorable histology Wilms tumor: Prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4
Norman E. Breslow, J. Bruce Beckwith, Gerald M. Haase, John A. Kalapurakal, Michael L. Ritchey, Robert C. Shamberger, Patrick R.M. Thomas, Giulio J. D’Angio, Daniel M. Green
Bilateral Wilms’ tumors with progressive or nonresponsive disease
Robert C. Shamberger, Gerald M. Haase, Pedram Argani, Elizabeth J. Perlman, Cecilia A. Cotton, Janice R. Takashima, Daniel M. Green, Michael L. Ritchey
The value of surgery in directing therapy for patients with Wilms’ tumor with pulmonary disease. A report from the National Wilms’ Tumor Study Group (National Wilms’ Tumor Study 5).
Peter F. Ehrlich, Thomas E. Hamilton, Paul E. Grundy, Michael L. Ritchey, Gerald M. Haase, Robert C. Shamberger
Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group
Paul E. Grundy, Norman E. Breslow, Sierra M. Li, Elizabeth Penman, J. Bruce Beckwith, Michael L. Ritchey, Robert C. Shamberger, Gerald M. Haase, Giulio J. D’Angio, Milton Donaldson, Max J. Coppes, Marcio H. Malogolowkin, Patricia Shearer, Patrick R.M. Thomas, Roger M. Macklis, Gail E. Tomlinson, Vicki Huff, Daniel M. Green
Fate of bilateral renal lesions missed on preoperative imaging: a report from the National Wilms Tumor Study Group.
Michael L. Ritchey, Robert C. Shamberger, Thomas E. Hamilton, Gerald M. Haase, Pedram Argani, Susan M. Peterson
Quality assessment for Wilms’ tumor: a report from the National Wilms’ Tumor Study-5.
Peter F. Ehrlich, Michael L. Ritchey, Tomas E. Hamilton, Gerald M. Haase, San Ou, Norman E. Breslow, Paul E. Grundy, Daniel M. Green, Patricia Norkool, Jennifer Becker, Robert C. Shamberger
Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.
Norman E. Breslow, San-San Ou, J. Bruce Beckwith, Gerald M. Haase, John A. Kalapurakal, Michael L. Ritchey, Robert C. Shamberger, Patrick R. M. Thomas, Giulio J. D’Angio, Daniel M. Green
Prophylactic Urokinase in the Management of Long-Term Venous Access Devices in Children: A Children’s Oncology Group Study
Peter W. Dillon, Gary R. Jones, Holly A. Bagnall-Reeb, Jonathon D. Buckley, Eugene S. Wiener, Gerald M. Haase
Efficacy of complete resection for high-risk neuroblastoma: a Children’s Cancer Group study.
E. Stanton Adkins, Robert S. Sawin, Robert B. Gerbing, Wendy B. London, Katherine K. Matthay, Gerald M. Haase
Effect of Duration of Treatment on Treatment Outcome for Patients With Clear-Cell Sarcoma of the Kidney: A Report From the National Wilms’ Tumor Study Group
Nita L. Seibel, Sierra M. Li, Norman E. Breslow, J. Bruce Beckwith, Daniel M. Green, Gerald M. Haase, Michael L. Ritchey, Patrick R.M. Thomas, Paul E. Grundy, Jerry Z. Finklestein, Tae Kim, Stephen J. Shochat, Panayotis P. Kelalis, Giulio J. D’Angio
Management of Wilms’ tumour: current practice and future goals.
John A. Kalapurakal, Jeffrey S. Dome, Elizabeth J. Perlman, Marcio H. Malogolowkin, Gerald M. Haase, Paul E. Grundy, Max J. Coppes
Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms’ tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms’ Tumor Study Group
John A. Kalapurakal, Sierra M. Li, Norman E. Breslow, J. Bruce Beckwith, Roger M. Macklis, Patrick R.M. Thomas, G J D’Angio, Tae Kim, Alfred de Lorimier, Panayotis P. Kelalis, Steven Shochat, Michael L. Ritchey, Gerald M. Haase, Ellen E. Hrabovsky, H.Biemann Otherson, Paul E. Grundy, Daniel M. Green
Low-Level Radiation Risk
Kedar N. Prasad, William C. Cole, Gerald M. Haase
Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study.
Daphne A. Haas-Kogan, Patrick S. Swift, Michael T. Selch, Gerald M. Haase, Robert C. Seeger, Robert B. Gerbing, Daniel O. Stram, Katherine K. Matthay
National action plan for childhood cancer: report of the national summit meetings on childhood cancer.
Robert J. Arceci, Alice Ettinger, Edwin N. Forman, Gerald M. Haase, G. Denman Hammond, Rutht Hoffman, Mary Jo Kupst, Michael P. Link, Craig Lustig, Dianne S Traynor
The occurrence of Wilms tumor in horseshoe kidneys: a report from the National Wilms Tumor Study Group (NWTSG).
Holly L. Neville, Michael L. Ritchey, Robert C. Shamberger, Gerald M. Haase, Sharon Perlman, Teri Yoshioka
Intravascular Extension of Wilms Tumor
Robert C. Shamberger, Michael L. Ritchey, Gerald M. Haase, Tracy L. Bergemann, Teri Loechelt-Yoshioka, Norman E. Breslow, Daniel M. Green
Childhood cancer: patterns of protocol participation in a national survey.
Stephen J. Shochat, Amy M. Fremgen, Sharon B. Murphy, Carol Hutchison, Sarah S. Donaldson, Gerald M. Haase, Arthur J. Provisor, Rosemarie E. Clive‐Bumpus, David P. Winchester
Surgical complications after primary nephrectomy for Wilms’ tumor: report from the National Wilms’ Tumor Study Group
Michael L. Ritchey, Robert C. Shamberger, Gerald M. Haase, Jeffrey R. Horwitz, Tracy L. Bergemann, Norman E. Breslow
Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children’s Cancer Group ☆ ☆☆
Michael P. La Quaglia, Thomas Black, George Holcomb, Charles A. Sklar, Richard G. Azizkhan, Gerald M. Haase, Kurt D. Newman
Biologic Factors Determine Prognosis in Infants With Stage IV Neuroblastoma: A Prospective Children’s Cancer Group Study
Mary Lou Schmidt, John N. Lukens, Robert C. Seeger, Garrett M. Brodeur, Hiroyuki Shimada, Robert B. Gerbing, Daniel O. Stram, Carlos A. Perez, Gerald M. Haase, Katherine K. Matthay
Children will benefit as pediatric groups merge: a surgical oncologist’s perspective.
Gerald M. Haase
Biologic Variables in the Outcome of Stages I and II Neuroblastoma Treated With Surgery as Primary Therapy: A Children’s Cancer Group Study
Carlos A. Perez, Katherine K. Matthay, James B. Atkinson, Robert C. Seeger, Hiroyuki Shimada, Gerald M. Haase, Daniel O. Stram, Robert B. Gerbing, John N. Lukens
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
Steven G. DuBois, Yan Kalika, John N. Lukens, Garrett M. Brodeur, Robert C. Seeger, James B. Atkinson, Gerald M. Haase, C T Black, Carlos A. Perez, Hiroyuki Shimada, Robert B. Gerbing, Daniel O. Stram, Katherine K. Matthay
Current aspects of biology, risk assessment, and treatment of neuroblastoma.
Gerald M. Haase, Carlos Perez, James B. Atkinson
Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4.
Robert C. Shamberger, Katherine A. Guthrie, Michael L. Ritchey, Gerald M. Haase, Janice R. Takashima, J. Beckwith, Giulio J. D’Angio, Daniel M. Green, Norman E. Breslow
Gastric Necrosis After Fundoplication: A Novel Approach for Esophageal Preservation
Kathryn D Bass, David P Meagher, Gerald M Haase
Survivorship in childhood cancer : A case statement for enhancement of the role of the American Cancer Society
Gerald M. Haase, Alvin M. Mauer, Gregory H. Reaman
Pharmacokinetics of Once-Daily Gentamicin Dosing in Pediatric Patients
Kathryn D Bass, Susan E Larkin, Chris Paap, Gerald M. Haase
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children’s Cancer Group study.
Katherine K. Matthay, Carlos A. Perez, Seeger Rc, Garrett M. Brodeur, H. Shimada, James B. Atkinson, C T Black, Robert B. Gerbing, Gerald M. Haase, Daniel O. Stram, Patrick S. Swift, John N. Lukens
Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children’s Cancer Group.
Kurt D. Newman, Thomas J. Black, Glenn Heller, Richard G. Azizkhan, George Holcomb, Charles A. Sklar, Vaia Vlamis, Gerald M. Haase, Michael P. La Quaglia
The international neuroblastoma risk groups (INRG): a preliminary report
R.P Castleberry, Jon Pritchard, Peter F. Ambros, Frank Berthold, Garrett M. Brodeur, Victoria Castel, Susan L. Cohn, B. De Bernardi, C Dicks-Mireaux, D. Frappaz, Gerald M. Haase, Michelle Haber, D. Jones, Vijay V. Joshi, M Kaneko, J.T Kemshead, Per Kogner, R.E.J Lee, Katherine K. Matthay, Jean Michon, R Monclair, B.R Roald, Seeger Rc, Peter J. Shaw, H. Shimada, Jonathan J. Shuster
Intra‐operative radiation therapy in pediatric neuroblastoma
Patrick J. Leavey, Lorrie F. Odom, M A Poole, L. McNeely, R. W. Tyson, Gerald M. Haase
Quality of life research in childhood cancer. The time is now.
Gregory H. Reaman, Gerald M. Haase
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children’s Cancer Group studies.
Daniel O. Stram, Katherine K. Matthay, Michael P. O’Leary, C. P. Reynolds, Gerald M. Haase, James B. Atkinson, Garrett M. Brodeur, Robert C. Seeger
Renal salvage procedures in patients with synchronous bilateral Wilms’ tumors : A report from the National Wilms’ Tumor Study Group
Jeffrey R. Horwitz, Michael L. Ritchey, Jami Moksness, Norman E. Breslow, Glenda R. Smith, Patrick R.M. Thomas, Gerald M. Haase, Robert C. Shamberger, J. Bruce Beckwith
Current surgical management of Wilms’ tumor.
Gerald M. Haase
Recurrent appendicitis after initial conservative management of appendiceal abscess
Mitchell R. Price, Gerald M. Haase, Kennith H. Sartorelli, David P. Meagher
Laparoscopic Thal Fundoplication with Gastrostomy in Children
Luis A. Martinez-Frontanilla, Kennith H. Sartorelli, Gerald M. Haase, David P. Meagher
Pelvic neuroblastoma–implications for a new favorable subgroup: a Children’s Cancer Group experience.
Gerald M. Haase, Maura O’Leary, Daniel O. Stram, John N. Lukens, Robert C. Seeger, Hiroyuki Shimada, Katherine K. Matthay
Minimally invasive surgery in children with cancer.
George W. Holcomb, Sandra S. Tomita, Gerald M. Haase, Peter W. Dillon, Kurt D. Newman, Harry Applebaum, Eugene S. Wiener
Neonatal soft tissue sarcomas: The influence of pathology on treatment and survival
Peter W. Dillon, Thomas V. Whalen, Richard G. Azizkhan, Gerald M. Haase, Arnold G. Coran, Denis R. King, Mark B. Smith
Neonatal Wilms tumor
Michael L. Ritchey, R G Azizkhan, J B Beckwith, Ellen E. Hrabovsky, Gerald M. Haase
Adaptation of an ECMO team in the era of successful alternative therapies for neonatal pulmonary failure
Gerald M. Haase, Jan M Kennaugh, David R. Clarke
Metastatic neuroblastoma–does combining several “magic bullets” make a difference?
Gerald M. Haase
Diagnosis, management, and outcome of cervicofacial teratomas in neonates: A Childrens Cancer Group study☆
Richard G. Azizkhan, Gerald M. Haase, Harry Applebaum, Peter W. Dillon, Arnold G. Coran, Phillip A King, Denis R. King, David Hodge
Surgical Management and Outcome of Locoregional Neuroblastoma: Comparison of the Childrens Cancer Group and the International Staging Systems
Gerald M. Haase, James B. Atkinson, Daniel O. Stram, John N. Lukens, Katherine K. Matthay
Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent children’s cancer group results
Katherine K. Matthay, Maura O’Leary, Norma K.C. Ramsay, Judith G. Villablanca, C.P. Reynolds, James B. Atkinson, Gerald M. Haase, D.O. Stram, Robert C. Seeger
The implications of surgical quality assurance in cancer clinical trials.
Gerald M. Haase
Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
Katherine K. Matthay, Robert C. Seeger, C. P. Reynolds, Daniel O. Stram, Maura O’Leary, Richard E. Harris, Michael T. Selch, James B. Atkinson, Gerald M. Haase, Norma K.C. Ramsay
Electron beam intraoperative radiation therapy for pediatric neoplasms
Gerald M. Haase, David P. Meagher, Lee K. McNeely, William E. Daniel, A B S Marten Poole, B A Marilyn Blake, Lorrie F. Odom
Indications for Surgical Intervention for Gastrointestinal Emergencies in Children Receiving Chemotherapy
Christopher C. Silliman, Gerald M. Haase, John D. Strain, Dennis W. Luckey, A B A Marilyn Blake, Sherrie A. Caldwell, Harry L. Wilson, Lorrie F. Odom, Joann L. Ater, C.M. Brian S. Greffe M.D.
A prospective randomized trial of delayed versus immediate repair of congenital diaphragmatic hernia
Masaki Nio, Gerald M. Haase, Jan M Kennaugh, Kim Chi Bui, James B. Atkinson
Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.
Katherine K. Matthay, Robert C. Seeger, C. P. Reynolds, Daniel O. Stram, Maura O’Leary, Richard E. Harris, Michael T. Selch, James B. Atkinson, Gerald M. Haase, G D Hammond
Small bowel obstruction after nephrectomy for Wilms’ tumor. A report of the National Wilms’ Tumor Study-3.
Michael L. Ritchey, Panayotis P. Kelalis, Ruth Etzioni, Norman E. Breslow, Stephen J. Shochat, Gerald M. Haase
Current management of Wilms’ tumor
Michael L. Ritchey, Gerald M. Haase, Stephen J. Shochat
Current biologic and therapeutic implications in the surgery of neuroblastoma.
Richard G. Azizkhan, Gerald M. Haase
Preoperative therapy for intracaval and atrial extension of Wilms tumor
Michael L. Ritchey, Panayotis P. Kelalis, Gerald M. Haase, Stephen J. Shochat, Daniel M. Green, Giulio D’Angio
Incidental appendectomy during nephrectomy for Wilms’ tumor
Michael L. Ritchey, G. M. Haase, S. J. Shochat, P. P. Kelalis
Resection of the primary tumor is appropriate for children with stage IV-S neuroblastoma: an analysis of 37 patients.
Deborah A. Martinez, Denis R. King, Margaret E. Ginn-Pease, Gerald M. Haase, Eugene S. Wiener
Superior mesenteric artery injury during nephrectomy for Wilms’ tumor
Michael L. Ritchey, Kevin P. Lally, Gerald M. Haase, Stephen J. Shochat, Panayotis P. Kelalis
Surgical complications after nephrectomy for Wilms’ tumor.
Michael L. Ritchey, P. P. Kelalis, Norman E. Breslow, R. Etzioni, I. Evans, G. M. Haase, G. J. D’angio
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastoma
Gerald M. Haase, Maura O’Leary, Norma K.C. Ramsay, Steven G. Romansky, Daniel O. Stram, Robert C. Seeger, G. Denman Hammond
Right atrial catheters in pediatric oncology: a patient/parent questionnaire study.
Marten A. Poole, Mitchell N. Ross, Gerald M. Haase, Lorrie F. Odom
Assessing children with chalasia: rule out gastroesophageal reflux.
Bonnie Gance-Cleveland, Gerald M. Haase
A surgical perspective on the current staging in neuroblastoma–the International Neuroblastoma Staging System proposal.
E. Ide Smith, Gerald M. Haase, Robert C. Seeger, Garrett M. Brodeur
Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy.
Katherine K. Matthay, Harland N. Sather, Robert C. Seeger, Gerald M. Haase, G D Hammond
Improvement in survival after excision of primary tumor in stage III neuroblastoma.
Gerald M. Haase, Kwan Y. Wong, Alfred A. deLorimier, Harland N. Sather, G. Denman Hammond
An Alternative Approach to Management of Fogarty Catheter Disruption Associated with Endobronchial Foreign Body Extraction
Mitchell N. Ross, Gerald M. Haase
The importance of acid reflux patterns in neurologically damaged children detected by four-channel esophageal pH monitoring.
Mitchell N. Ross, Gerald M. Haase, Thomas T. Reiley, David P. Meagher
An evaluation of the role of surgery in metastatic neuroblastoma.
Mitsuyoshi Matsumura, Jarnes B. Atkinson, Daniel M. Hays, G. Denman Hammond, Stuart E. Siegel, Harland N. Sather, Jay L. Grosfeld, Gerald M. Haase
Extended four-channel esophageal pH monitoring: the importance of acid reflux patterns at the middle and proximal levels.
Gerald M. Haase, Mitchell N. Ross, Bonnie Gance-Cleveland, Kathi E. Kolack
International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma.
Garrett M. Brodeur, Seeger Rc, A Barrett, Robert P. Castleberry, Giulio J. D’Angio, De Bernardi B, Audrey E. Evans, Favrot M, A I Freeman, Gerald M. Haase
A unique teletransmission system for extended four-channel esophageal pH monitoring in infants and children
Gerald M. Haase, David P. Meagher, Edward Goldson, William H. Falor
Nephroblastomatosis and Wilms’ tumor. Clinical experience and management of seven patients.
Richard L. Heideman, Gerald M. Haase, Christopher L. Foley, Harry Wilson, William C. Bailey
Surgical complications in Henoch-Schönlein purpura
Luis A. Martinez-Frontanilla, Gerald M. Haase, Joel A. Ernster, Wm. Carl Bailey
Surgery of acquired lobar emphysema in the neonate.
Luis A. Martinez-Frontanilla, Jacinto Hernandez, Gerald M. Haase, John D. Burrington
Rhabdomyosarcoma of the biliary tree: The case for aggressive surgery*
Luis A. Martinez-F, Gerald M. Haase, Lawrence J. Koep, David R. Akers
Selective management of injured spleen.
Denis R. King, Lobe Te, Gerald M. Haase, Boles Et
Prospective evaluation of radionuclide scanning in detection of intestinal necrosis in neonatal necrotizing enterocolitis
Gerald M. Haase, George N. Sfakianakis, Thom E Lobe, E. Thomas Boles
The value of radionuclide bone scanning in the early recognition of deliberate child abuse.
Gerald M. Haase, Victor N. Ortiz, George N. Sfakianakis, Thomas S. Morse
Glucagon in experimental intussusception
Gerald M. Haase, E. Thomas Boles
Partial splenectomy in staging laparotomy for Hodgkin’s disease: An alternative approach*
E. Thomas Boles, Gerald M. Haase, Ala B. Hamoudi
The value of radionuclide scanning in early diagnosis of intestinal infarction
Victor N. Ortiz, George N Sfakianakis, Gerald M. Haase, E. Thomas Boles
In vivo radionuclide imaging to detect intestinal necrosis.
Gerald M. Haase, George N. Sfakianakis, Victor N. Ortiz, Lobe Te, Boles Et
Muscle surface pH as a monitor of tissue perfusion and acid-base status.
Robert M. Filler, John B. Das, Gerald M. Haase, Patricia K. Donahoe
Dr. Gerald Haase is a Clinical Professor of Surgery at the University of Colorado School of Medicine and Children’s Hospital Colorado. Dr. Haase has been active in clinical research trials for three decades including collaborations in the design of central venous access devices, applications of intra-operative radiation therapy for treatment of pediatric tumors, evaluation of technical surgical innovations in adult and childhood cancer, and development of novel strategies for antioxidant micronutrient therapy for war fighter protection, against hazardous exposures, for certain chronic conditions, and for optimal health. He received a B.A. degree from Johns Hopkins University, his M.D. degree from Tufts University School of Medicine and was awarded graduate honors in medical research. His post-graduate training was at the University of Colorado, the Children’s Hospital Medical Center, Boston, and the Children’s Hospital, Columbus, Ohio. In clinical practice, he was board certified in general surgery, pediatric surgery and critical care. He was Chairman of Pediatric Surgery at Children’s Hospital Colorado, and consultant pediatric surgeon to the Department of the Army. Dr. Haase served as vice-chairman of the Children’s Cancer Group, a cooperative research consortium of the National Cancer Institute. He was a member of the National Board of Directors of the American Cancer Society and its representative to the Alliance for Childhood Cancer. He is the author or co-author of 175 scientific publications, holds twelve U.S. patents for antioxidant micronutrient therapy and been the recipient of clinical research grants and contracts funded at a multi-million dollar cumulative level.
Get our free Healthy Heart Docs Weekly Newsletter sent by email once a week. Packed with the latest tips for heart health, cardiovascular health, nutritional guidance, and performance tips from our Medical Editors. No selling, no purchases, no credit card required, cancel any time; just educational information sent straight to your inbox once a week. Strict no-spam policy.
Our weekly newsletter is a free service of Healthy Heart Docs.
"*" indicates required fields